The appellant entered into three successive restraint of trade agreements in 1992, 1996, and 1998. The first was with Macmed Health Care Limited in 1992 for R350,000, requiring him to refrain from competing with the Macmed group during employment and for two years after termination. In 1996, after a joint venture was created with Kendall International, he signed a second agreement with International Latex Products (Pty) Ltd for R1,250,000 with a six-month post-employment restraint. In 1998, with the Macmed group's turnover having grown substantially and the Standard Bank becoming heavily involved, a third agreement for R3,000,000 was concluded with a two-year post-employment restraint. Each agreement contained a clause (4.4) allowing the appellant to buy himself out of the restraint by repaying the consideration received. The Commissioner for SARS assessed all three payments as income, arguing they were disguised remuneration rather than genuine restraint of trade payments. The Tax Court allowed the appeal concerning the R350,000 (1992) but disallowed the appeals for the R1,250,000 (1996) and R3,000,000 (1998), holding that no additional asset or resource was surrendered under the later agreements.
The appeal was upheld with costs, including those of two counsel. The order of the Tax Court was set aside. The 1998 assessment and the portions of the 1996 assessment relating to all three amounts (R350,000, R1,250,000, and R3,000,000) were set aside and referred back to the Commissioner for reassessment on the basis that none of the three amounts fell within the taxpayer's gross income.
Where an employee enters into successive restraint of trade agreements with the same employer (or group), each agreement can give rise to a capital receipt even if the restraint terms are substantially identical, provided the employee surrenders an additional asset or resource. The surrender of the right to obtain release from an earlier restraint by repaying a lower buyout amount constitutes the disposal of a capital asset where the employee's commercial value as an unfettered worker exceeds the buyout amount. Payments received as consideration for agreeing to restraints of trade are capital receipts, being compensation for the sterilization of income-earning capacity, not income receipts subject to tax (at least before the 2000 amendments to the Income Tax Act). The court must look not merely at the form of transactions but at their real nature and commercial substance, reading related agreements together.
The Court noted that clause 4.4 of the agreements (allowing buyout) was apparently based on a similar clause in ITC 1338, 43 SATC 171. While the Tax Court had speculated that the payments might have been retainers to induce the appellant to remain in employment or bonuses for past services, the SCA did not need to decide this issue. Farlam JA emphasized that on the undisputed evidence, the appellant genuinely considered the agreements to contain valid restraints and that the consideration did not represent disguised remuneration. The Court also noted that the Macmed group's turnover had grown substantially from R22 million (1992) to R90 million (1996) to R456 million (1998), contextualizing the increasing restraint payments.
This case is significant in South African tax law as it clarifies that successive restraint of trade agreements can each give rise to capital receipts, even where the restraint terms are substantially similar. The judgment emphasizes substance over form and recognizes that the surrender of a right to buy oneself out of an existing restraint constitutes the disposal of a capital asset. The case is particularly important as it was decided before the amendment to the Income Tax Act (Act 30 of 2000) which inserted paragraph (cA) into the definition of 'gross income' to specifically include certain restraint of trade payments in gross income. The decision demonstrates the application of the 'sterilization of income-earning capacity' principle to complex commercial scenarios involving corporate groups and successive agreements. It also illustrates the proper approach to interpreting multiple related agreements together to ascertain their true commercial effect.